Acurx Pharmaceuticals, Inc. (ACXP) Net Income by Year
Acurx Pharmaceuticals, Inc. reported a net loss of $8.0M in fiscal year 2025. This represents an increase of 43.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Acurx Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ACXP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ACXP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Acurx Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Acurx Pharmaceuticals, Inc.'s net income in fiscal year 2025?
Acurx Pharmaceuticals, Inc. reported a net loss of $8.0M in fiscal year 2025.
How fast is Acurx Pharmaceuticals, Inc.'s net income growing?
Acurx Pharmaceuticals, Inc. (ACXP) net income rose by 43.5% year over year, from -$14.1M to -$8.0M in fiscal year 2025.
How has Acurx Pharmaceuticals, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Acurx Pharmaceuticals, Inc. (ACXP) net income went from -$4.6M in fiscal year 2020 to -$8.0M in fiscal year 2025.
What was Acurx Pharmaceuticals, Inc.'s net income in the most recent quarter?
Acurx Pharmaceuticals, Inc. (ACXP) reported -$2.3M in net income in Q2 2026. This represents a decrease of 0.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Acurx Pharmaceuticals, Inc. (ACXP) reported on that line in every period on record.